Screener
Opko Health OPK Pharmaceutical — Goodwill Foreign Currency Translation Gain Loss
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Opko Health in its filing.
Tagged under the XBRL concept us-gaap:GoodwillForeignCurrencyTranslationGainLoss.
The source filing: Opko Health’s 10-Q, filed July 27, 2026.
- Filed
- Jul 27, 2026, 4:12 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-318090
| (In thousands) | 2026 / Grossgoodwill at January 1,2026 | 2026 / Cumulativeimpairmentat January 1 | 2026 / Foreignexchangeand other | 2026 / Balance at June 30, 2026 |
|---|---|---|---|---|
| Pharmaceuticals | ||||
| CURNA | $4,827 | $(4,827) | — | — |
| Rayaldee | 89,510 | — | (2,473) | 87,037 |
| FineTech | 11,698 | (11,698) | — | — |
| ModeX | 80,260 | — | — | 80,260 |
| OPKO Biologics | 139,784 | — | — | 139,784 |
| OPKO Chile | 3,553 | — | (82) | 3,471 |
| OPKO Health Europe | 7,740 | — | (219) | 7,521 |
Item 1. Financial Statements
FAQ
- What is Opko Health's pharmaceutical — goodwill foreign currency translation gain loss?
- Opko Health (OPK) reported pharmaceutical — goodwill foreign currency translation gain loss of -$715K in Q2 2026.
- What does pharmaceutical — goodwill foreign currency translation gain loss mean?
- The impact of fluctuations in foreign exchange rates on the carrying value of goodwill denominated in currencies other than the reporting currency for the pharmaceutical segment. It captures non-cash adjustments resulting from the translation of international pharmaceutical assets.
Ask your AI about Opko Health's pharmaceutical — goodwill foreign currency translation gain loss.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude